Endovascular treatment for ischemic stroke: state of the art
STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick...
-
Upload
philomena-walters -
Category
Documents
-
view
219 -
download
0
Transcript of STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick...
![Page 1: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/1.jpg)
STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASEMr. Patrick Chong Consultant Vascular & Endovascular Surgeon
Surrey Heart, Stroke and Vascular CentreFrimley Health NHS Foundation TrustGuildford November
2014
![Page 2: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/2.jpg)
Stroke – the figures
3rd leading cause of death and
120 000 new strokes annually500 000 new strokes annually
3 times as many women die from stroke as from breast cancer.
![Page 3: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/3.jpg)
Stroke – the costs$51 billion - Stroke related treatment
costs and disability payments in 2003
£7 billion – Stroke related treatment costs and disability payments in 2005
Treatment and research under funded in the UK?£2 million per annum in the UK
c.f. Cancer £120 million and Heart Disease £43 million
Rothwell 2001 Lancet
![Page 4: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/4.jpg)
The dangers of stroke
1 in 4 men before 85 years old1 in 5 women before 85 years old
30% of stroke patients die within 30 days
Up to 32% will have a recurrent stroke within 30 days1 in 4 stroke patients have a recurrent stroke
![Page 5: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/5.jpg)
Brain Attack!
Vladimir C. Hachinski MD Canadian Neurologist
r-TPA currently the only FDA approved treatment for acute stroke to be givenwithin 4.5 HOURS of the start of symptoms.
The majority of patients don't report to the emergency room until more than 24 hours after the onset of stroke symptoms
52 % of acute stroke patients unaware they were experiencing a stroke.
![Page 6: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/6.jpg)
Current organisation of care in UKNational Sentinel Audit
2004 2006 2010Stroke units 71% 91% 83%Thrombolysis offered 18% 50%Neurovascular clinics 65% 78% 98%
Rapid transfer protocols 4% 12% 22%
High risk patients seen < 7 days 35% 43%
TIA clinic median waiting (days) 14 12 3 1 FPH
![Page 7: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/7.jpg)
Current emergency care in UKNational Sentinel Audit 2006 vs. 2010 vs. 2014
Access to brain imaging < 12 hours 48% vs. 87%
Access to brain imaging < 24 hours 95% vs. 99%
Thrombolysis offered to eligible pts 18% vs. 50% vs. 80%
WHAT HAS CHANGED?
Stroke Telemedicine
Ambulance Services Pre-alerts
24 imaging and reporting for CT / CT in ED
ED led thrombolysis
![Page 8: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/8.jpg)
“There is more to stroke prevention than CEA” – AR Naylor 2007
![Page 9: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/9.jpg)
Risk factors for stroke
Modifiable Hypertension Smoking Hyperlipidaemia High grade carotid stenosis Atrial Fibrillation Diabetes Controversial e.g. OCP, Obesity, Alcohol Non-modifiable Age Male sex Ethnicity
![Page 10: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/10.jpg)
![Page 11: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/11.jpg)
Fate of symptomatic carotid disease Stroke incidence
1 Year 5 years
Previous Symptoms
TIA 12-13% 30-35%Stroke 5-9% 25-45%
Norris JW et al. Stroke 1991
![Page 12: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/12.jpg)
Fate of asymptomatic carotid disease 1 Year
< 75% ICA stenosis 1.5% Stroke
> 75% ICA stenosis 3.3% Stroke
7.5% TIA
Norris JW et al. Stroke 1991
![Page 13: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/13.jpg)
Does plaque morphology matter?Risk of stroke in symptomatic patients
95% stenosis 21% Non-ulcerated plaque
95% stenosis 73%Ulcerated plaque NASCET study 1991
![Page 14: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/14.jpg)
Does symptomatic carotid stenosis matter?
![Page 15: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/15.jpg)
Which patients should be treated first? 4799 patients tested using ABCD (2) score
2-day risk of stroke
Score of 0 – 3 (1012 patients) 1%Score of 4 – 5 (2169 patients) 4.1%Score of 6 – 7 (1628 patients) 8.1%
Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007
![Page 16: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/16.jpg)
Carotid Endarterectomy (CEA)
![Page 17: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/17.jpg)
The earliest reportLoucks et al. 1936Union Medical College, Beijing, China.
Young male with recurrent TIAsRight hemiplegia and aphasiaExcision of ICA occlusionPatient recovered
Archives of Surgery 1938
![Page 18: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/18.jpg)
Speed is of the essence!
First carotid endarterectomy1953De Bakey JAMA 1975
Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia Eastcott, Pickering and Rob Lancet 1954
![Page 19: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/19.jpg)
The evolution of carotid surgery
Reported 1955
Reported 1975
Reported 1954
![Page 20: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/20.jpg)
Pre-CEA imaging – current UK Duplex only 65%
Duplex and MRA 13% Duplex and arch angiogram 9% Duplex and CTA 6% MRA only 2% CTA only 2% Arch angiogram only
2%
GALA trial preliminary dataGough et al. 2007Leeds
![Page 21: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/21.jpg)
Mofidi et al. 2006
![Page 22: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/22.jpg)
To patch or not to patch?GALA Trial (current UK practice)
Always 75%Selective 20%Never 5%
“Patch angioplasty versus primary closure for CEA”Bond et al. 2003Cochrane Database of Systematic Reviews
Outcome no different for different patch types
Significant reductionsStrokeDeathEarly ThrombosisLate Restenosis
![Page 23: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/23.jpg)
Intra-operative cerebral perfusionNever shunt 5%
Speed
Shunt all patients 70%Mainly GA patients
Selectively shunt 25%Stump pressures 25%EEG 5%TCD 35%Awake patient – regional cervical block
“Routine or selective carotid artery shunting for CEA”Bond et al. 2001Cochrane Database of Systematic ReviewsNo evidence to support a policy of routine, selective or no shunting
![Page 24: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/24.jpg)
How does surgery compare with best medical therapy in symptomatic carotid disease?
PrimaryPrimary
EndpointEndpoint
TrialTrial NN StenosisStenosis
(%)(%)MedicalMedical
(%)(%)SurgicalSurgical
(%)(%)P P
valuevalueARRARR
(%)(%)NNTNNT
NASCETNASCET
19911991659659 >70>70 32.332.3 15.815.8 <0.00<0.00
1111.311.3 99
ECSTECST
1991199130083008 >70>70 21.921.9 12.312.3 <0.00<0.00
111.51.5 6868
VASSTVASST
19911991189189 >50>50 19.419.4 7.77.7 0.010.01 17.217.2 66
![Page 25: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/25.jpg)
Surgery versus Stenting outcomesCAVATAS
2001
LEXINGTON 1
2001SAPPHIRE
2004
EVA-3S
2006
SPACE
2006
ICSS
2010
CREST
2010
CEA / CAS CEA / CAS CEA / CAS
71%
No
Symptoms
CEA / CAS CEA / CAS CEA / CAS CEA / CAS
Number
randomised
253 / 251 53 / 51 151 / 156 262 / 265 595 / 605 855 / 858 1251 / 1271
Cranial nerve
8.7% / 0% 8.0 % / NS 5.3% / 0% 7.7% / 1.1% NS / NS 5.3% / 0.1% 4.7% / 0.3%
Wound 6.7%/ 1.2 % 8.0% / 0 % 10.6% / 8.3%
1.2% / 3.1% NS / NS 5.8% / 3.6% 0.2% / 1.6%
Stroke 9.9% / 10% 0% / 0% 20 % / 12% / 9.6% 7.4 % / 6.8% 4.1% / 7.5% 2.3 %/ 4.1%
Death 2 % / 3 % 1.9% / 0 % Combined 6%
1.2% / 0.8% 0.9% / 0.7% 0.8% / 2.2% 0.3% / 0.7%
Combined
Death
Any Stroke
5.9% / 6.4% 1.9% / 0% 6.1 % / 5.8%
For AS patients
3.9% / 9.6% 6.5% / 7.7% 5.2% / 8.5% 3.2% / 6.0%
![Page 26: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/26.jpg)
What would you rather choose?
![Page 27: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/27.jpg)
Are you sure you still want a stent?
![Page 28: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/28.jpg)
Carotid endarterectomy outcomes
N=159N=159
2007-20102007-2010*N=2236*N=2236
2007 J Vas 2007 J Vas SurgSurg
*N=5513*N=5513
20082008
30-day Stroke / 30-day Stroke / TIA (%)TIA (%)
3.1% (n=5)3.1% (n=5) 1.4%1.4% 1.8%1.8%
30-day MI (%)30-day MI (%) 2.5% (n=4)2.5% (n=4) 0.5%0.5% 0.8%0.8%
30-day Death 30-day Death (%)(%)
3.1% (n=5)3.1% (n=5) 0.6%0.6% 0.5%0.5%
Cranial Nerve Cranial Nerve Injuries (%)Injuries (%)
2.1% (n=2)2.1% (n=2) 0.4%0.4% 4.5%4.5%
Return to Return to theatrestheatres
0.6% (n=1) NSNS 2.1%2.1%
Median length Median length of stay (days)of stay (days)
33 4.34.3 33Asymptomatic patients 8.8% FPH 64% MGH16% NVD
![Page 29: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/29.jpg)
Institution No. of Procedures
PatientsDischargedWithout stroke / death in 30 days
Adjusted rate of stroke / death %
Days from symptom to surgery Median (IQR)
Length of stay (days)Median (IQR)
FPH 211 207 2.0 8 (5,12)
2 (1,5)
National
2.5 12
Vascular Services Quality Improvement Programme (VSQIP)November 2014
Surgeon outcomes for carotid endarterectomy
Dates 1st October 2010 to 30th September 2013
![Page 30: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/30.jpg)
Rationale for delaying CEA Risks of haemorrhagic transformation
infarctwith early surgery in acute stroke
Delay of 4-6 weeks recommended
Wylie (1964)Thompson (1970)DeWeese (1971)Torgovnick (2007)
![Page 31: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/31.jpg)
When should surgery be offered?Risk of stroke andtiming of carotid endarterectomy
![Page 32: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/32.jpg)
DOES TIMING OF SURGERY MATTER?Carotid Endarterectomy Trialists Collaboration (CETC)
Number of ipsilateral strokes prevented at five years by performing 1000 CEAs in symptomatic patients with 50-99% stenoses relative to days from last symptom to surgery (based on reanalysis of CETC data) Rothwell Lancet 2004
![Page 33: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/33.jpg)
Faster surgery for females
“Benefit from CEA in women was apparent in those randomized within 2 weeks of their last symptomatic ischemic event”
“Current guidelines in Europe and the USA which state only that CEA should be performed within 6 months of last symptoms should be amended in the light of these results.”
Rothwell PM et al. Stroke 2004; 35: 2855-2861.
![Page 34: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/34.jpg)
Delays! Delays! Delays!
Median time to surgery Days
UK national carotid audit 1997 189Newcastle audit 1995 120Oxford audit 2005 100 GALA trial 2008 82Frimley Park Hospital 2007-08 67Frimley Park Hospital 2010-2014
8
![Page 35: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/35.jpg)
University of Calgary experience Stroke 2006
12% admitted patients required surgery 72% operated within 2 weeks in 2002 92% operated within 2 weeks in 2004
37% operated within 2 weeks on NVD 14% operated within 2 weeks at Frimley in 2010 100% operated within 2 weeks at Frimley in 2014
![Page 36: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/36.jpg)
43 consecutive patients 12 months prior to NICE stroke guidelines (July 2008)
All TIA or non-disabling stroke
94% patients scored ABCD2 > 4 (high risk) Mean time to consultant vascular opinion 28 days 81% patients had carotid duplex within 7 days 32% of high risk patients had CT scan within 24
hours 14% of patients had surgery within 2 weeksASIT Conference Nottingham March 2009
![Page 37: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/37.jpg)
Conclusions (in 2008)
WE WERE NOT FAST ENOUGH!
Significant delays existed in our local urgent carotid surgery pathway prior to the NICE guidelines (July 2008).
![Page 38: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/38.jpg)
According to NICEHow quickly do we need to investigate & Treat symptomaticCarotid Stenosis?
7 days
South East CoastStroke Clinical ReferenceGroup target for CEA
48hrs from diagnosis
![Page 39: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/39.jpg)
Stroke and TIA Surgical Helpline – allow direct consultant to consultant referrals from HASU and acute stroke unites from RSCH, BNHH and HWPH SEND IMAGES VIA IEP and FAX PATIENT DETAILS
GPs to refer to their nearest HASU or Acute Stroke units or Rapid Access TIA clinic - MDT
![Page 40: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/40.jpg)
Limitations of CEA Severe OA / ankylosis cervical spine Long length lesions High bifurcations (above C2) Previous cervical surgery Previous cervical irradiation Concomitant intra-cranial lesion Concomitant thoracic lesion Medically “high risk” patient
![Page 41: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/41.jpg)
The first report of endoluminal carotid intervention“Catheter dilatation of proximal
carotid stenosis during distal bifurcation endarterectomy.”
Kerber CW et al. 1980
Am J Neuroradiol
![Page 42: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/42.jpg)
Carotid artery stenting (CAS)
![Page 43: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/43.jpg)
Overview of CASPatient preparation
Femoral access
Aortic arch angiogram
Selective arch vessel cannulation
Intracranial and extracranial cannulation
Common carotid sheath access
EPD placement
Predilatation, stenting and postdilatation
Completion angiogram
EPD removal
Access site management
Postprocedural care and followup
![Page 44: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/44.jpg)
Catch of the day!
![Page 45: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/45.jpg)
Risk of micro-emboli: CAS vs. CEA Diffusion-weighted MRI
Events in the 48 hours following CEA and CAS. 19 / 27 (70%) CAS vs. 0 / 19 (0%) CEA
9 ipsilateral / 7 bilateral / 3 contralateral
3 CAS patients had post-operative neurology but all resolved within 36 hours.
The only factor associated with the development of microemboli was the use of a diagnostic arch angiogram.
Preoperative MRI/A or CT-A recommended as alternative instead
![Page 46: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/46.jpg)
NICE guidance for CAS
Safe and efficacious in the short term
Unsure about benefits in asymptomatic
Clear written information with consent
Audit and review all cases
Submit cases to registries and studiesLast updated September
2006
![Page 47: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/47.jpg)
Asymptomatic carotid disease- what was known before ACST
ACAS (USA) 1995
If a patient had a CEA before developing symptoms, they might be less likely to have a stroke, providing the operation had a very low morbidity and mortalityBenefits confined to men under 65 yearsNo difference in outcome for stenosis 60-99%Benefits were not greater for those with tighter stenosis as seen in the symptomatic trials
MAJORITY OF PATIENTS IN USA & EUROPEAN SERIES ARE ASYMPTOMATIC!
ACST (UK) 2003
1560 allocated immediate CEA1560 allocated follow-up with deferred CEA3.4 years mean follow-up
![Page 48: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/48.jpg)
Asymptomatic Carotid StudiesTotal 5 year Stroke related mortality
![Page 49: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/49.jpg)
What we know post ACST
Benefits significant for men as well as for women up to the age of 75 years.
Benefits seen in patients with a stenosis > 70% on ultrasound.
5 year net risk of all strokes in ACST.6% with immediate CEA12% with deferred CEA
Fatal and disabling stroke, not just stroke overall was prevented by surgery.
![Page 50: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/50.jpg)
ACST Caveats Best medical therapy (BMT) not optimised.
Higher event rates compared with medical trials. Surgeons with event rates > 3%?
CAPRIE (n= 19185) 2 yr Stroke, MI, Vascular Death 5.8% ASA vs. 5.3% Plavix
4S study (n=4444) Simvastatin 2.7% vs. Placebo 4.3%
No plaque morphology characterisation.
![Page 51: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/51.jpg)
RCTs of CEA for asymptomatic diseasePrimary
Endpoint
Trial N Stenosis
(%)
Medical
(%)
Surgical
(%)
P value
ARR
(%)
NNT
VA
1993
444 >50 20.6 8 <0.001 3 32
ACAS
1995
1662 >60 11 5.1 0.004 1.2 85
CASANOVA
2001
410 50-90 NS NS NS NS NS
ACST
2004
3120 >60 11.8 6.4 <0.001 1.1 93
![Page 52: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/52.jpg)
Future asymptomatic data ECST-2
Role of BMT + Surgery vs. BMT FPH will be recruiting Dr. Giosue Gulli PI
ACST -2 Role of CEA vs. CAS. Funding approved. Now recruiting.
TACIT Role of BMT vs. BMT + CEA vs. BMT + CAS
![Page 53: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/53.jpg)
Timing of surgery and efficacy Risks of further stroke are the highest in the
first 2 weeks following TIA/Minor stroke
Early carotid surgery is safe in ASA I / II patients following stable, non-disabling stroke
Safer to delay ASA III / IV patients
Patients with large areas of brain injury on CT or MRI
Patients with unstable symptoms are at higher risk of peri-operative stroke
![Page 54: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/54.jpg)
Future role for Best medical therapy?
Antiplatelets
NOACs
Statins
Antihypertensives
![Page 55: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/55.jpg)
Can we go faster?RACE (Rapid Access Carotid Endarterectomy)
Follow the local Stroke/TIA pathways Refer to TIA clinic or ED Stroke units to admit high risk ABCD2 > 4 patients Fast track investigations for TIA/Stroke Surgical referral to vascular surgeon – USE
HOTLINE Inform colleagues in primary and secondary care
![Page 56: STROKE AND TIA - OPTIMAL SURGICAL MANAGEMENT OF SYMPTOMATIC CAROTID DISEASE Mr. Patrick ChongConsultant Vascular & Endovascular Surgeon Surrey Heart, Stroke.](https://reader036.fdocuments.in/reader036/viewer/2022062322/56649e255503460f94b139cf/html5/thumbnails/56.jpg)
SummaryThe use of a stroke/TIA pathway to expedite access to assessment Imaging and treatment is mandatory.
Carotid endarterectomy remains the “gold standard” in intervention for symptomatic carotid disease.
The ideal patient group for CAS remains to be defined and long term results from ICSS and CREST are awaited. The traditional indications for CAS still hold. CAS patients should be entered into registries.
There is no place for the routine screening of patients for asymptomatic carotid disease.